3 Reasons to Buy Moderna Stock
Although (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in the COVID-19 vaccine market catapulted it to new heights.
However, once the pandemic began subsiding, with a substantial decline in coronavirus-related sales, Moderna's shares suffered. They're down by 25% over the past three years. Is Moderna just a pandemic stock?
Not at all. Let's consider three reasons why investing in the company today is worth it.
Source Fool.com
Moderna Inc. Stock
Currently there is a rather positive sentiment for Moderna Inc. with 11 Buy predictions and 8 Sell predictions.
However, we have a potential of -61.85% for Moderna Inc. as the target price of 21 € is below the current price of 55.04 €.


